Evidence map›Paper›PMID 35745260›Full record

ArticleNutrients2022

Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet.

Zhixin Luo, Mengqian Li, Qiong Yang, Yuhong Zhang, Fang Liu, Lan Gong, Lin Han, Min Wang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Ferulic acid: a liver protector.Frontiers in pharmacology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Water Extract ofInternational journal of molecular sciences · 2024
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zhixin LuoCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Mengqian LiCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Qiong YangCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Yuhong ZhangInstitute of Food Science and Technology, Tibet Academy of Agricultural and Animal Husbandry Sciences, Lhasa 850000, China.
Fang LiuCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Lan GongMicrobiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0003-3136-1565
Lin HanCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Min WangCollege of Food Science and Engineering, Northwest A&F University, Yangling, Xianyang 712100, China.
Northwest A&F University · CNInstitute of Food Science and Technology · CNSutherland Hospital · AU

Funding

Key R&D program of Shaanxi China 2020ZDLNY05-07Key R&D program of Shaanxi China 2021NY-126
6 · The paper itself

Abstract

There is a consensus that ferulic acid (FA), the most prominent phenolic acid in whole grains, displays a protective effect in non-alcoholic fatty liver disease (NAFLD), though its underlying mechanism not fully elucidated. This study aimed to investigate the protective effect of FA on high-fat diet (HFD)-induced NAFLD in mice and its potential mechanism. C57BL/6 mice were divided into the control diet (CON) group, the HFD group, and the treatment (HFD+FA) group, fed with an HFD and FA (100 mg/kg/day) by oral gavage for 12 weeks. Hematoxylin and eosin (H&E) staining and Oil Red O staining were used to evaluate liver tissue pathological changes and lipid accumulation respectively. It was demonstrated that FA supplementation prevented HFD-induced NAFLD, which was evidenced by the decreased accumulation of lipid and hepatic steatosis in the HFD+FA group. Specifically, FA supplementation decreased hepatic triacylglycerol (TG) content by 33.5% (p < 0.01). Metabolic cage studies reveal that FA-treated mice have elevated energy expenditure by 11.5% during dark phases. Mechanistically, FA treatment increases the expression of rate-limiting enzymes of fatty acid oxidation and ketone body biosynthesis CPT1A, ACOX1 and HMGCS2, which are the peroxisome proliferator-activated receptors α (PPARα) targets in liver. In conclusion, FA could effectively prevent HFD-induced NAFLD possibly by activating PPARα to increase energy expenditure and decrease the accumulation of triacylglycerol in the liver.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCoumaric AcidsDiet, High-FatEnergy MetabolismFatty AcidsLiverMiceMice, Inbred C57BLPPAR alphaTriglyceridesCoumaric AcidsFatty Acidsferulic acidPPAR alphaTriglyceridesenergy expenditureferulic acidketone body biosynthesisNAFLDβ-oxidation

Identifiers

PMID35745260
PMCPMC9230086
OpenAlexW4283119287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.